by Dag Aarsland
A joint symposium between the EANM Neuroimaging Committee and EAN will take place during the EANM (European Association of Nuclear Medicine) Virtual Multidisciplinary Days on 28-30 June, 2022.
Prof. Dag Aarsland, a member of the Management Group of the EAN Scientific Panel on Dementia and cognitive disorders, will give a presentation on Workflow in suspected Dementia with Lewy Bodies and Motor Taupathies.
Dementia with Lewy bodies (DLB) is a neurodegenerative disease with unique clinical and pathological features. The prognosis for most people is poor, and drug management is complicated and requires a fine-tuned balance between helping and harming the patient. Early, accurate diagnosis is therefore crucial but can be challenging. Biomarkers with good sensitivity and specificity are available and even included in the diagnostic criteria. Recently, there has been an increased focus on the pre-dementia stages, including the MCI stage, labelled MCI-LB. There is emerging work suggesting that biomarkers such as dopamine transporter PET or SPECT, and EEG, may be helpful also at the predementia stage, but more research is needed. Similarly, the potential role of the new seeding technique, RT-QUIC, to diagnose prodromal DLB needs to be explored. These aspects will be discussed in this presentation.
The joint session is scheduled for Tuesday, 30 June, 2022 (Channel 3). For further details please visit the EANM Virtual Multidisciplinary Days website.
